Form 8-K - Current report:
SEC Accession No. 0001564590-20-039704
Filing Date
2020-08-12
Accepted
2020-08-12 16:24:25
Documents
3
Period of Report
2020-08-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pcvx-8k_20200812.htm 8-K 40273
2 EX-99.1 pcvx-ex991_6.htm EX-99.1 286418
3 GRAPHIC gqolfekm5hfw000001.jpg GRAPHIC 2754
  Complete submission text file 0001564590-20-039704.txt   331823
Mailing Address 353 HATCH DR FOSTER CITY CA 94404
Business Address 353 HATCH DR FOSTER CITY CA 94404 650-837-0111
Vaxcyte, Inc. (Filer) CIK: 0001649094 (see all company filings)

EIN.: 464233385 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39323 | Film No.: 201095736
SIC: 2836 Biological Products, (No Diagnostic Substances)